Further, during the tumor killing stage by cytotoxic T lymphocytes (CTLs), the PD-1/PD-L1 pathway for immune escape of tumor cells was inhibited by the local release of anti-PD-1. The gene discussed is PDCD1; the disease is neoplasm.